Because the above-described expression patterns of MTSS1 in primary AML samples suggest a possible role of this gene in chemotherapy responsiveness, MTSS1-proficient and -deficient TF-1-derivative cell lines were treated with various concentrations of araC or DNR and subjected to viability assays. The gene discussed is MTSS1; the disease is acute myeloid leukemia.